BCIQ Profiles

Company Profile Report

TCR2 raises $75M in IPO

TCR2 Therapeutics Inc. (NASDAQ:TCRR) raised $75 million in an IPO priced Feb. 13. The immuno-oncology company priced 5 million shares

Read the full 204 word article

How to gain access

Continue reading with a
two-week free trial.